You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LXEO Sale Disclosure
Townsend Richard Nolan · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$16.56K
Townsend Richard Nolan Chief Executive Officer
LXEO
Lexeo Therapeutics
LXEO
Transaction date
Aug 18, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 1 day later
LXEO daily price context
Close on/before transaction
$4.93
Aug 18, 2026
First close after public filing
$5.06
Aug 20, 2026
30-day return after filing
-17.0%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,345 shares @ $4.95
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001995218-26-000015
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$16.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lexeo Therapeutics, Inc. LXEO Current | Sale | Aug 18, 2026 | $16.56K |